Anti-Human MICA/MICB (6D4)
MICA/MICB Monoclonal Antibody for FC
Host / Isotype
Mouse / IgG2a, kappa
Reactivity
Human and More (1)
Applications
FC and More (1)
Conjugate
Unconjugated
CloneNo.
6D4
验证数据展示
经过测试的应用
Positive FC detected in | HeLa cells |
推荐稀释比
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
WB | See 3 publications below |
产品信息
65161-1-Ig targets MICA/MICB in WB, FC applications and shows reactivity with Human samples.
Tested Applications | FC Application Description |
Cited Applications | WB |
Tested Reactivity | Human |
Cited Reactivity | human |
Immunogen | Transfected C1R cells expressing MICA 种属同源性预测 |
Host / Isotype | Mouse / IgG2a, kappa |
Class | Monoclonal |
Type | Antibody |
Full Name | MHC class I polypeptide-related sequence A |
Synonyms | MICA, MICB |
Calculated Molecular Weight | 383 aa, 43 kDa |
GenBank Accession Number | BC016929 |
Gene Symbol | MICA |
Gene ID (NCBI) | 100507436 |
RRID | AB_2881478 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Purified by protein-A affinity chromatography |
UNIPROT ID | Q29983 |
Storage Buffer | PBS with 0.09% sodium azide. |
Storage Conditions | Store at 2-8°C. Stable for one year after shipment. |
背景介绍
实验方案
Product Specific Protocols | |
---|---|
FC protocol for MICA/MICB antibody 65161-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
J Immunother BCMA-targeting Bispecific Antibody That Simultaneously Stimulates NKG2D-enhanced Efficacy Against Multiple Myeloma. | ||
Int Immunopharmacol Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway. | ||
Cancers (Basel) circRNF10 Regulates Tumorigenic Properties and Natural Killer Cell-Mediated Cytotoxicity against Breast Cancer through the miR-934/PTEN/PI3k-Akt Axis |